This excerpt taken from the CVS 8-K filed Jun 30, 2006.
Item 7.01 Regulation FD Disclosure
On June 2, 2006, CVS Corporation (CVS) and its wholly owned subsidiary, CVS Pharmacy, Inc. (CVS Pharmacy), completed the acquisition of, approximately 700 standalone drugstores and a distribution center in La Habra, California (collectively the Standalone Drug Business) from Albertsons, Inc. (Albertsons). The Standalone Drug Business includes retail drugstores located primarily in southern California, Illinois, Arizona, Indiana, Nevada, Missouri, Wisconsin and Kansas.
CVS acquisition of the Standalone Drug Business is structured as an asset purchase, with a purchase price under the Asset Purchase Agreement of $3.93 billion. CVS obtained funding for the acquisition through a combination of proceeds from its Bridge Facility and the issuance of commercial paper. CVS expects to repay a portion of the commercial paper borrowing with longer term financing during the third quarter of 2006. In addition, CVS expects to monetize all or a substantial portion of the owned real estate interests relating to the acquired drugstores for up to $1.0 billion in a sale lease-back transaction.
The information in this report is being furnished, not filed, pursuant to Item 7.01 of Form 8-K. Accordingly, the information in this report will not be incorporated by reference into any registration statement filed by the Company under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference.
This excerpt taken from the CVS 8-K filed Dec 23, 2005.
Item 7.01. Regulation FD Disclosure
On December 22, 2005, CVS Corporation issued a press release announcing discussions with Albertsons, Inc., regarding a purchase of Albertsons standalone Sav-on and Osco drugstores have been terminated. Attached to this Current Report on Form 8-K as Exhibit 99.1, is a copy of the Corporations related press release dated December 22, 2005.
The information in this report is being furnished, not filed. Accordingly, the information in Item 9.01 of this report will not be incorporated by reference into any registration statement filed by the Corporation under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference.